diethylnitrosamine has been researched along with propranolol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurkalo, VK; Zabezhinskiĭ, MA | 1 |
| Ameri, L; Arias, E; Girotti, P; Mazzoleni, G; Presta, M; Radaelli, G; Ragnotti, G; Zavanella, T | 1 |
| Cardani, R; Radaelli, G; Ragnotti, G; Zavanella, T | 1 |
3 other study(ies) available for diethylnitrosamine and propranolol
| Article | Year |
|---|---|
[Modification of chemical carcinogenesis with adrenergic compounds].
Topics: Adrenergic alpha-Antagonists; Animals; Cell Transformation, Neoplastic; Diethylnitrosamine; Drug Antagonism; Esophageal Neoplasms; Liver Neoplasms; Male; Neoplasms, Experimental; Nitrosamines; Norepinephrine; Propranolol; Rats | 1978 |
Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats.
Topics: Animals; Atenolol; Body Weight; Carcinogens; Diethylnitrosamine; Female; gamma-Glutamyltransferase; Liver; Liver Neoplasms, Experimental; Male; Organ Size; Precancerous Conditions; Propranolol; Rats; Rats, Inbred F344; Sex Factors | 1994 |
Influence of beta-adrenergic antagonists on cell proliferation rates in the kidney of untreated and diethylnitrosamine-treated male F344 rats.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Body Weight; Carcinogens; Cell Division; Diethylnitrosamine; Eating; Kidney; Male; Organ Size; Propranolol; Rats; Rats, Inbred F344; Retrospective Studies | 1999 |